1. Introduction
===============

Mangroves are woody plants located in tropical and subtropical intertidal coastal regions, which are high productive ecosystems \[[@B1-marinedrugs-11-00817],[@B2-marinedrugs-11-00817]\]. Novel bioactive compounds have been reported from the plant materials \[[@B3-marinedrugs-11-00817],[@B4-marinedrugs-11-00817],[@B5-marinedrugs-11-00817]\]. Mangrove streptomycetes are also potential resources for the discovery of anti-infection, anti-tumor and hypoglycemic compounds \[[@B6-marinedrugs-11-00817],[@B7-marinedrugs-11-00817],[@B8-marinedrugs-11-00817],[@B9-marinedrugs-11-00817],[@B10-marinedrugs-11-00817]\]. *Streptomyces* sp. 211726, a remarkable producer of macrocyclic lactones, was selected from 288 strains when we carried on the chemical screening for macrolide-producing mangrove actinomycetes. Five azalomycin F analogs including azalomycins F~3a~, F~4a~, F~5a~, azalomycin F~4a~ 2-ethylpentyl ester and azalomycin F~5a~ 2-ethylpentyl ester were identified from the culture broth of this strain in our previous work \[[@B11-marinedrugs-11-00817]\], while the HPLC profiles of the methanol extract and several macrolide constituents indicated that many azalomycin F analogs were produced by this strain. After the relative configurations of azalomycins F~3a~, F~4a~ and F~5a~ were assigned \[[@B12-marinedrugs-11-00817]\], further research on minor azalomycin F analogs produced by this strain led to seven new compounds ([Figure 1](#marinedrugs-11-00817-f001){ref-type="fig"}) which were respectively identified as 25-malonyl demalonylazalomycin F~5a~ monoester (**1**), 23-valine demalonylazalomycin F~5a~ ester (**2**), 23-(6-methyl)heptanoic acid demalonylazalomycins F~3a~ (**3**), F~4a~ (**4**) and F~5a~ (**5**) esters, 23-(9-methyl)decanoic acid demalonylazalomycin F~4a~ ester (**6**) and 23-(10-methyl)undecanoic acid demalonylazalomycin F~4a~ ester (**7**). Their structures were established by their spectroscopic data (IR, UV, NMR, MS) and by comparing with those of azalomycins F~3a~, F~4a~ and F~5a~ which were reported in our previous paper \[[@B11-marinedrugs-11-00817]\], and their complete ^1^H and ^13^C assignments were achieved by using ^1^H, ^13^C, DEPT, HSQC, ^1^H-^1^H COSY and HMBC spectra in MeOH-*d*~4~. Moreover, biological assays of **1**--**7** showed broad-spectrum antimicrobial activity as well as anti HCT-116 activity.

![Structure of compounds **1**--**7** from Mangrove *Streptomyces* sp. 211726.](marinedrugs-11-00817-g001){#marinedrugs-11-00817-f001}

2. Results and Discussion
=========================

2.1. Structural Elucidation
---------------------------

25-Malonyl demalonylazalomycin F~5a~ monoester (**1**) was obtained as a white, amorphous powder with \[α\]~D~^29^ +6.7° (*c* 0.1, MeOH). Its molecular formula C~57~H~97~N~3~O~17~ was established by the HRESIMS spectrometric data at *m*/*z* 1096.6914 \[M + H\]^+^ (calcd. for C~57~H~98~N~3~O~17~, 1096.6896), which showed that its molecular formula was identical to that of azalomycin F~5a~. Like azalomycin F~5a~, its UV absorption maxima at 241 nm (log ε, 4.6) and 269 nm (log ε, 4.3) also indicated the presence of a conjugated diene and an α,β,γ,δ-unsaturated acid (or ester) group. The ^13^C, DEPT and HSQC spectra of **1** ([Table 1](#marinedrugs-11-00817-t001){ref-type="table"}) showed one guanidino carbon signal at δ~C~ 157.42, three carbonyl carbon signals at δ~C~ 170.2, 171.9 and 173.9, ten olefinic carbon signals at δ~C~ 125.3, 126.8, 127.6, 128.6, 130.3, 132.6, 136.3, 140.2, 140.3 and 146.2, one quaternary hemiacetical carbon at δ~C~ 99.9 and one methine carbon at δ~C~ 70.8. So, **1** was deduced as an isomer of azalomycin F~5a~. When we compared the ^13^C and DEPT spectra of **1** with those of azalomycin F~5a~ \[[@B13-marinedrugs-11-00817]\], the signal at δ~C~ 46.6 (C-26) in the ^13^C NMR spectrum of azalomycin F~5a,~ was not observed while a signal at δ~C~ 44.0 appeared in that of **1**. Based on the HSQC, ^1^H-^1^H COSY and HMBC spectra of **1**, the linking position of the malonyl group was assigned to C-25 in **1**, and the signal at δ~C~ 44.0 was assigned to C-26. It is interesting that **1** was found to be convertible to azalomycin F~5a~. HPLC analysis showed that the ratio of **1** to azalomycin F~5a~ was about 15:85 after **1** stood in MeOH-*d*~4~ at room temperature for 30 days. This phenomenon was also observed by Iwasaki S. *et al.* \[[@B14-marinedrugs-11-00817]\]. The compound convertible to azalomycin F~5a~ was named as azalomycin F~5b~, although spectroscopic information and structure of azalomycin F~5b~ was not given in the paper \[[@B14-marinedrugs-11-00817]\]. There is not enough evidence to confirm that **1** and azalomycin F~5b~are the same compound. So, **1** was identified as 25-malonyl demalonylazalomycin F~5a~ monoester.
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NMR spectroscopic data (400 MHz for ^1^H, 100 MHz for ^13^C) of **1**, **2**, **3** and **6** in MeOH-*d*~4~ (δ in ppm).

  Position   1       2                      3       6                                                                                    
  ---------- ------- ---------------------- ------- ---------------------- ------- ---------------------- ------- ---------------------- --
  C-1        170.2   \-                     170.1   \-                     170.1   \-                     170.1   \-                     
  C-2        126.8   \-                     126.7   \-                     126.8   \-                     126.8   \-                     
  C-3        140.3   7.09 d (11.2)          140.3   7.10 d (11.0)          140.2   7.10 d (11.2)          140.3   7.10 d (11.0)          
  C-4        127.6   6.43 dd (11.5, 14.9)   127.6   6.43 dd (11.5, 14.7)   127.6   6.43 dd (11.9, 14.3)   127.6   6.43 dd (11.5, 14.8)   
  C-5        146.2   6.07 dd (15.1, 9.0)    146.1   6.08 dd (14.8, 9.0)    146.1   6.08 dd (14.0, 9.0)    146.1   6.08 dd (14.9, 9.0)    
  C-6        44.8    2.43 m                 44.7    2.44 m                 44.6    2.43 m                 44.7    2.44 m                 
  C-7        75.9    3.80 m                 75.8    3.77 m                 75.8    3.77 m                 75.8    3.77 m                 
  C-8        39.3    1.50 m, 1.78 m         39.3    1.50 m, 1.78 m         39.3    1.50 m, 1.77 m         39.3    1.50 m, 1.78 m         
  C-9        75.4    3.80 m                 75.2    3.80 m                 75.2    3.80 m                 75.2    3.80 m                 
  C-10       44.7    1.54 m                 44.6    1.53 m                 44.5    1.54 m                 44.6    1.53 m                 
  C-11       72.2    3.91 m                 72.2    3.87 m                 72.2    3.91 m                 72.2    3.87 m                 
  C-12       33.5    1.62 m, 1.38 m         33.5    1.60 m, 1.38 m         33.5    1.62 m, 1.37 m         33.4    1.62 m, 1.37 m         
  C-13       30.7    1.30 m, 1.45 m         30.6    1.30 m, 1.42 m         30.6    1.30 m, 1.43 m         30.6    1.30 m, 1.43 m         
  C-14       40.6    1.60 m                 40.5    1.61 m                 40.7    1.61 m                 40.5    1.61 m                 
  C-15       72.7    3.86 m                 72.7    3.87 m                 72.4    3.86 m                 72.7    3.87 m                 
  C-16       41.9    1.80 m                 41.8    1.81 m                 41.9    1.82 m                 41.8    1.81 m                 
  C-17       99.9    \-                     100.0   \-                     99.8    \-                     99.9    \-                     
  C-18       77.5    3.34 d (9.2)           77.4    3.35 d (9.1)           77.2    3.35 d (9.2)           77.5    3.35 d (9.1)           
  C-19       69.9    3.87 m                 69.9    3.88 m                 69.7    3.87 m                 69.8    3.88 m                 
  C-20       41.4    1.89 m, 1.30 m         41.3    1.89 m, 1.30 m         41.2    1.90 m, 1.31 m         41.3    1.89 m, 1.31 m         
  C-21       65.7    4.17 m                 66.2    4.16 m                 66.3    4.16 m                 66.3    4.16 m                 
  C-22       44.5    1.52 m                 41.9    1.82 m                 41.8    1.88 m                 41.9    1.81 m                 
  C-23       66.3    4.03 m                 70.9    5.29 m                 70.7    5.27 m                 70.9    5.29 m                 
  C-24       44.6    1.69 m                 44.0    1.70 m                 44.0    1.72 m                 44.1    1.76 m, 1.66 m         
  C-25       70.8    5.28 m                 65.7    3.86 m                 65.6    3.87 m                 65.7    3.86 m                 
  C-26       44.0    1.61 m, 1.83 m         46.3    1.51 m                 46.4    1.51 m                 46.3    1.51 m                 
  C-27       65.7    3.88 m                 65.8    4.04 m                 65.6    4.04 m                 65.8    4.04 m                 
  C-28       44.2    1.78 m                 44.1    1.54 m                 44.1    1.53 m                 44.1    1.63 m                 
  C-29       74.2    4.18 m                 74.2    4.18 m                 74.2    4.18 m                 74.2    4.18 m                 
  C-30       140.2   \-                     140.1   \-                     140.1   \-                     140.1   \-                     
  C-31       125.3   5.98 d (10.4)          125.3   5.98 d (10.7)          125.2   5.98 d (10.5)          125.3   5.98 d (10.7)          
  C-32       128.6   6.22 dd (10.9, 14.5)   128.5   6.23 dd (10.9, 14.9)   128.6   6.22 dd (10.9, 14.9)   128.5   6.23 dd (10.9, 14.8)   
  C-33       136.3   5.43 m                 136.3   5.44 m                 136.2   5.45 m                 136.3   5.44 m                 
  C-34       41.0    2.57 m                 40.7    2.57 m                 41.0    2.57 m                 40.9    2.57 m                 
  C-35       80.9    4.78 dd (7.6, 4.0)     80.9    4.79 dd (7.7, 4.1)     80.8    4.78 dd (7.8, 3.9)     80.9    4.79 dd (7.6, 4.1)     
  C-36       35.3    1.82 m                 35.3    1.82 m                 35.2    1.81 m                 35.3    1.82 m                 
  C-37       34.4    1.15 m, 1.35 m         34.4    1.15 m, 1.35 m         34.5    1.15 m, 1.35 m         34.4    1.15 m, 1.35 m         
  C-38       27.9    1.42 m                 27.8    1.42 m                 27.9    1.41 m                 27.9    1.42 m                 
  C-39       33.6    1.99 m                 33.6    1.99 m                 33.6    1.99 m                 33.6    1.99 m                 
  C-40       132.6   5.44 m                 132.5   5.44 m                 132.6   5.44 m                 132.6   5.44 m                 
  C-41       130.3   5.44 m                 130.3   5.44 m                 130.1   5.50 m                 130.2   5.44 m                 
  C-42       30.7    2.07 m                 30.4    2.07 m                 30.8    2.07 m                 30.6    2.07 m                 
  C-43       29.9    1.67 m                 29.8    1.64 m                 29.8    1.64 m                 29.8    1.64 m                 
  C-44       42.2    3.17 t (7.3)           42.0    3.15 t (7.1)           42.0    3.15 t (7.0)           42.0    3.15 t (7.1)           
  C-45       12.9    1.92 s                 12.9    1.92 s                 12.9    1.92 s                 12.9    1.92 s                 
  C-46       17.1    1.11 d (6.8)           17.1    1.12 d (6.8)           17.1    1.11 d (6.8)           17.1    1.12 d (6.8)           
  C-47       10.5    0.89 d (6.9)           10.5    0.89 d (6.9)           10.5    0.89 d (6.9)           10.5    0.89 d (6.9)           
  C-48       15.2    0.91 d (6.7)           15.3    0.92 d (6.7)           15.3    0.91 d (6.7)           15.3    0.92 d (6.7)           
  C-49       13.1    1.65 s                 13.1    1.65 s                 13.3    1.65 s                 13.1    1.65 s                 
  C-50       17.8    1.01 d (6.7)           17.9    1.00 d (6.7)           17.9    1.00 d (6.6)           17.9    1.00 d (6.8)           
  C-51       14.4    0.94 d (6.7)           14.5    0.95 d (6.7)           14.4    0.94 d (6.7)           14.5    0.94 d (6.7)           
  C-52       157.4   \-                     157.4   \-                     158.7   \-                     158.3   \-                     
  C-53a      28.4    2.85 s                 28.4    2.85 s                                                28.4    2.84 s                 
  C-53b      28.4    2.85 s                 28.4    2.85 s                                                                               
  C-1′       171.9   \-                     174.1   \-                     175.5   \-                     175.4   \-                     
  C-2′       46.0    3.22 m                 61.7    3.44 d (4.0)           35.0    2.36 t (7.4)           35.0    2.36 t (7.5)           
  C-3′       173.9   \-                     30.8    2.28 m                 26.0    1.62 m                 26.0    1.61 m                 
  3′-CH~3~                                  17.9    1.02 d (6.8)                                                                         
  C-4′                                      19.2    1.07 d (6.8)           30.4    1.42 m                 30.3    1.35 m                 
  C-5′                                                                     40.3    1.18 m                 30.4    1.31 m                 
  C-6′                                                                     29.2    1.29 m                 30.8    1.30 m                 
  6′-CH~3~                                                                 23.8    0.88 d (6.6)                                          
  C-7′                                                                     23.7    0.88 d (6.6)           28.5    1.29 m                 
  C-8′                                                                                                    40.3    1.17 m                 
  C-9′                                                                                                    29.2    1.31 m                 
  9′-CH~3~                                                                                                23.1    0.89 d (6.8)           
  C-10′                                                                                                   23.1    0.89 d (6.8)           

23-Valine demalonylazalomycin F~5a~ ester (**2**) was obtained as a white, amorphous powder with \[α\]~D~^29^ +4.4° (*c* 0.1, MeOH). Its molecular formula C~59~H~104~N~4~O~15~ was established by the HRESIMS spectrometric data at *m*/*z* 1109.7580 \[M + H\]^+^ (calcd. for C~59~H~105~N~4~O~15~, 1109.7576). Its UV absorption maxima at 241 nm (log ε, 4.6) and 268 nm (log ε, 4.4) indicated the presence of a conjugated diene and an α,β,γ,δ-unsaturated acid (or ester) group. The ^13^C, DEPT and HSQC spectra of **2** ([Table 1](#marinedrugs-11-00817-t001){ref-type="table"}) showed one guanidino carbon signal at δ~C~ 157.4, one carbonyl carbon signal at δ~C~ 170.1, ten olefinic carbon signals at δ~C~ 125.3, 126.7, 127.6, 128.5, 130.3, 132.5, 136.3, 140.1, 140.3 and 146.1, one quaternary hemiacetical carbon signal at δ~C~ 100.0, one methine carbon signal at δ~C~ 70.9 and two *N*-methyl carbon signals at δ~C~ 28.4. These spectroscopic data were very similar to azalomycin F~5a~ reported in our previous paper \[[@B11-marinedrugs-11-00817]\], while there was no carbonyl carbon signal at δ~C~ 171.6 and methylene carbon signal at δ~C~ 46.1. Comparing the ^13^C, DEPT and HSQC spectra of **2** and those of azalomycin F~5a~, two additional methyl carbon signals at δ~C~ 17.9 and 19.2 and two methylene carbon signals at δ~C~ 30.81 and 61.7 were present. Based on the correlations ([Figure 2](#marinedrugs-11-00817-f002){ref-type="fig"}) observed in the ^1^H-^1^H COSY and HMBC spectra of **2**, a valyl group was established. Moreover, the correlation between H-23 (δ~H~ 5.29) and C-1′ (δ~C~ 174.1) observed in the HMBC spectrum of **2** indicated that the valyl group was linked to the lactonic ring at C-23 with an ester bond. So, **2** was identified as 23-valine demalonylazalomycin F~5a~ ester.

![Key ^1^H-^1^H COSY and HMBC correlations of the valyl moiety in **2**.](marinedrugs-11-00817-g002){#marinedrugs-11-00817-f002}

23-(6-Methyl)heptanoic acid demalonylazalomycin F~3a~ ester (**3**) was obtained as a white, amorphous powder with \[α\]~D~^20^ +6.8° (*c* 0.1, MeOH). Its molecular formula C~60~H~105~N~3~O~15~ was established by the HRESIMS spectrometric data at *m*/*z* 1108.7638 \[M + H\]^+^ (calcd. for C~60~H~106~N~3~O~15~, 1108.7624). Its UV absorption maxima at 238 nm (log ε, 4.6) and 269 nm (log ε, 4.3) indicated the presence of a conjugated diene and an α,β,γ,δ-unsaturated acid (or ester) group. The ^13^C, DEPT and HSQC spectra of **3** ([Table 1](#marinedrugs-11-00817-t001){ref-type="table"}) showed one guanidino carbon signal at δ~C~ 158.7, one carbonyl carbon signal at δ~C~ 170.1, ten olefinic carbon signals at δ~C~ 125.2, 126.8, 127.6, 128.6, 130.1, 132.6, 136.2, 140.1, 140.2 and 146.1, one quaternary hemiacetical carbon signal at δ~C~ 99.8 and one methine carbon signal at δ~C~ 70.7. These spectroscopic data were very similar to those of azalomycin F~3a~ \[[@B15-marinedrugs-11-00817]\], which were reported as supporting information in our previous paper \[[@B11-marinedrugs-11-00817]\], while there were no carbonyl carbon signals at δ~C~ 171.8 and 174.0 and methylene carbon signal at δ~C~ 45.8 in the ^13^C NMR spectrum of **3**. Comparing the ^1^H, ^13^C, DEPT and HSQC spectra of **3** with those of azalomycin F~3a~, two additional methyl carbon signals at δ~C~ 23.8 and 23.7, four methylene carbon signals at δ~C~ 40.3, 35.0, 30.4 and 26.0, one methine carbon signal at δ~C~ 29.2 and a carbonyl carbon signal at δ~C~ 175.5 were observed in the ^13^C NMR spectrum of **3**. Based on the correlations observed in the ^1^H-^1^H COSY and HMBC spectra ([Figure 3](#marinedrugs-11-00817-f003){ref-type="fig"}), a 6-methyl heptanoyl group was deduced. Moreover, the correlations between H-23 (δ~H~ 5.27) and C-1′ (δ~C~ 175.5) observed in the HMBC spectrum of **3** indicated that the 6-methyl heptanoyl group was linked to the lactonic ring at C-23 with an ester bond. So, **3** was identified as 23-(6-methyl)heptanoic acid demalonylazalomycin F~3a~ ester.

![Key ^1^H-^1^H COSY and HMBC correlations of the 6-methyl heptanoyl moiety in **3**.](marinedrugs-11-00817-g003){#marinedrugs-11-00817-f003}

23-(6-Methyl)heptanoic acid demalonylazalomycin F~4a~ ester (**4**) was obtained as a white, amorphous powder with \[α\]~D~^20^ +6.4° (*c* 0.1, MeOH). Its molecular formula C~61~H~107~N~3~O~15~ was established by the HRESIMS spectrometric data at *m*/*z* 1122.7788 \[M + H\]^+^ (calcd. for C~61~H~108~N~3~O~15~, 1122.7780). The difference of 14 mass units between **4** and **3** indicated that **4**has one methylene unit more than **3**. Similar ^1^H, ^13^C, DEPT spectra and UV absorption data allowed identification of these two compounds as analogs. Comparing the ^13^C and DEPT spectra of **4** with those of azalomycin F~4a~ \[[@B16-marinedrugs-11-00817]\], the guanidino carbon signal at δ~C~ 158.3 (C-52) indicated that one methyl group was linked to a guanidino nitrogen \[[@B11-marinedrugs-11-00817]\], which was also corroborated by a proton signal at δ~H~ 2.84 (3H, s, H-53a), a carbon signal at δ~C~ 28.4 (C-53a) and the correlation between H-53a and C-52 observed in the HMBC spectrum of **4**. So, **4** was identified as 23-(6-methyl)heptanoic acid demalonylazalomycin F~4a~ ester.

23-(6-Methyl)heptanoic acid demalonylazalomycin F~5a~ ester (**5)** was obtained as a white, amorphous powder with \[α\]~D~^20^ +6.1° (*c* 0.1, MeOH). Its molecular formula C~62~H~109~N~3~O~15~ was established by the HRESIMS spectrometric data at *m*/*z* 1136.7956 \[M + H\]^+^ (calcd. for C~62~H~110~N~3~O~15~, 1136.7937). The difference of 14 mass units between **5** and **4** indicated that **5** has one methylene unit more than **4**. Similar ^1^H, ^13^C, DEPT spectra and UV absorption data allowed identification of these two compounds as analogs. Comparing their ^1^H, ^13^C and DEPT spectra, the guanidino carbon signal at δ~C~ 157.4 indicated two methyl groups were linked to two guanidino nitrogens, which was also corroborated by proton signals at δ~H~ 2.84 (6H, s, H-53a and H-53b) and carbon signals at δ~C~ 28.4 (C-53a and C-53b) in the ^1^H and ^13^C NMR spectrum of **5**, respectively. So, **5** was identified as 23-(6-methyl)heptanoic acid demalonylazalomycin F~5a~ ester.

23-(9-Methyl)decanoic acid demalonylazalomycin F~4a~ ester (**6**) was obtained as a white, amorphous powder with \[α\]~D~^20^ +6.0° (*c* 0.1, MeOH). Its molecular formula C~64~H~113~N~3~O~15~ was established by the HRESIMS spectrometric data at *m*/*z* 1164.8269 \[M + H\]^+^ (calcd. for C~64~H~114~N~3~O~15~, 1164.8250). The difference of 42 mass units between **6** and **4** indicated that **6** has three methylene units more than **4**. Similar ^1^H, ^13^C, DEPT spectra ([Table 1](#marinedrugs-11-00817-t001){ref-type="table"}) and UV absorption data of **6** and **4** also allowed identification of these two compounds as analogs. Comparing their spectroscopic data indicated the fatty acyl side chain of **6** has three methylenes more than **4**, which was deduced by the ^1^H, ^13^C, DEPT, HSQC and HMBC spectra of **6**. The ^13^C and ^1^H assignments of the fatty acyl side chain of **6** were achieved by its ^1^H-^1^H COSY, HSQC and HMBC spectra and ACD/Lab 6.0 software. **6** was identified as 23-(9-methyl)undecanoic acid demalonylazalomycin F~4a~ ester.

23-(10-Methyl)undecanoic acid demalonylazalomycin F~4a~ ester (**7**) was obtained as a white, amorphous powder with \[α\]~D~^20^ +6.0° (*c* 0.1, MeOH). Its molecular formula C~65~H~115~N~3~O~15~ was established by the HRESIMS spectrometric data at *m*/*z* 1178.8426 \[M + H\]^+^ (calcd. for C~65~H~116~N~3~O~15~, 1178.8406). The difference of 14 mass units between **7** and **6** indicated that **7** has one methylene unit more than **6**. Similar ^1^H, ^13^C, DEPT spectra and UV absorption data of them allowed identification of these two compounds as analogs. Comparing their ^1^H, ^13^C and DEPT spectra, there was no obvious difference between the ^13^C NMR spectrum of **7** and **6** except that one methylene carbon signal at about δ~C~ 31.0 was presented in the ^13^C NMR spectrum of **7**. So, **7** was identified as 23-(10-methyl)decanoic acid demalonylazalomycin F~4a~ ester.

![Structures of **1**′--**7**′.](marinedrugs-11-00817-g004){#marinedrugs-11-00817-f004}

After the planar structures of **1**--**7** were established, we focused on their stereochemistries. As the core macrolide planar structures of **1**--**7** were accordingly identical to those of azalomycins F~5a~, F~4a~ or F~3a~, the relative configurations of the core macrolide structures of **1**--**7** except the structural fragment from C-23 to C-27 of **1** could be directly established by comparing their ^13^C and ^1^H NMR spectra with those of azalomycins F~5a~, F~4a~ or F~3a~ \[[@B11-marinedrugs-11-00817],[@B12-marinedrugs-11-00817],[@B13-marinedrugs-11-00817],[@B15-marinedrugs-11-00817],[@B16-marinedrugs-11-00817]\]. Similar spectroscopic data of their core macrolide structures deduced that the relative configurations of **1**--**7** except that at C-23/C-25/C-27 of **1** were accordingly identical to those of azalomycins F~5a~, F~4a~ or F~3a~. Like that of azalomycin F~5a~, the chemical shifts for C-21 (65.7 ppm), C-23 (66.3 ppm) and C-27 (65.7 ppm) lower than 68.0 ppm in MeOH-*d*~4~ deduced that the relavitve configuration at C-23/C-25/C-27 of **1** was also *anti*/*anti* according to the universal NMR Database **4** \[[@B12-marinedrugs-11-00817],[@B17-marinedrugs-11-00817]\], which was further confirmed by two facts that **1** could be convertible to azalomycin F~5a~ in MeOH-*d*~4~ at room temperature and that the chemical shift for C-23 was upfield by about 5.0 ppm when the malonyl group of azalomycin F~4a~ was removed \[[@B12-marinedrugs-11-00817]\]. Because the relative stereochemistries of C~6~--C~11~ to C~14~--C~36~stereogenic centers of azalomycins F~5a~ remain undefined in our previous work \[[@B12-marinedrugs-11-00817]\], azalomycin F~5a~ was one of two possible stereoisomers which the relative configuration at C~11~/C~14~ was *anti* or *syn*. Similarly, azalomycins F~4a~ and F~3a~ were respectively one of two possible stereoisomers like that of azalomycin F~5a~. So, each compound of **1**--**7** was one of two possible stereoisomers numbered **1**--**7** and **1**′--**7**′ presented in [Figure 1](#marinedrugs-11-00817-f001){ref-type="fig"}, [Figure 4](#marinedrugs-11-00817-f004){ref-type="fig"}, respectively.

2.2. Biological Assays
----------------------

Biological assays indicated that **1**--**7** had broad-spectrum antimicrobial activity. Their minimal inhibitory concentrations (MICs) against *Candida albicans* ATCC 10231, *Staphylococcus aureus* S014, *Bacillus subtilis* S028 and *Escherichia coli* S002 were respectively 1.56--6.25, 0.39--1.56, 0.20--0.78 and 3.13--25.00 μg/mL ([Table 2](#marinedrugs-11-00817-t002){ref-type="table"}). Moreover, they also showed moderate cytotoxicity against human colon tumor cell HCT-116 *in vitro* with IC~50~ values of 1.81--5.00 μg/mL ([Table 2](#marinedrugs-11-00817-t002){ref-type="table"}).

marinedrugs-11-00817-t002_Table 2

###### 

Minimal inhibitory concentrations (MICs) against test microbes and IC~50~ value against HCT-116 *in vitro*.

  Compounds              MICs (μg/mL)   IC~50~ (μg/mL)                  
  ---------------------- -------------- ---------------- ------ ------- ------
  1                      3.13           0.39             0.20   3.13    5.00
  2                      6.25           1.56             0.39   6.25    1.95
  3                      3.13           0.78             0.39   3.13    2.46
  4                      1.56           1.56             0.20   6.25    2.45
  5                      1.56           0.78             0.78   12.5    1.81
  6                      3.13           0.39             0.39   25.00   1.54
  7                      3.13           0.39             0.39   3.13    2.46
  Positive controls \*   2.0            0.50             0.20   2.0     0.18

\* Amphotericin B for *C*. *albicans*, oxacillin sodium for *S*. *aureus* and *B*. *subtilis*, kalamycin for *E*. *coli* and doxorubicin for HCT-116 were respectively used as positive controls.

2.3. Discussion
---------------

Azalomycin F complex, including azalomycins F~3a~, F~4a~, F~5a~ and several minor analogs, was first isolated from the broth of *Streptomyces hygroscopicus* var. *azalomyceticus* by Arai in 1959 \[[@B18-marinedrugs-11-00817],[@B19-marinedrugs-11-00817]\]. The structures of azalomycins F~3a~, F~4a~ and F~5a~ were progressively elucidated from 1982 to 2012 \[[@B12-marinedrugs-11-00817],[@B14-marinedrugs-11-00817],[@B20-marinedrugs-11-00817],[@B21-marinedrugs-11-00817],[@B22-marinedrugs-11-00817]\], while others minor analogs were not identified. *Streptomyces* sp. 211726, isolated from mangrove rhizosphere soil, showed a remarkable productivity of macrocyclic lactones, and five main components azalomycins F~3a~, F~4a~, F~5a~azalomycin F~4a~ 2-ethylpentyl ester and azalomycin F~5a~ 2-ethylpentyl ester produced by this strain were identified \[[@B11-marinedrugs-11-00817]\]. During our research on minor analogs produced by this strain, seven new compounds **1**--**7** were isolated and identified in this paper. Similar to these azalomycin F analogs, many 36-membered polyhydroxyl macrolides such as RS-22, guanidylfungins, amycins, niphimycin, malonylniphimycin, dihydroniphimycin, malonyl-4,5-dihydroniphimycin, shurimycins and others were identified \[[@B23-marinedrugs-11-00817],[@B24-marinedrugs-11-00817],[@B25-marinedrugs-11-00817],[@B26-marinedrugs-11-00817]\]. There are about thirty 36-membered polyhydroxyl macrolides identified so far, and almost all of them were produced by *Streptomyces*. These compounds possess broad-spectrum antimicrobial activity, and azalomycin F was also an inhibitor of type-I interleukin-1 receptor \[[@B27-marinedrugs-11-00817]\]. In our research on biological activity of azalomycin F analogs produced by *Streptomyces* sp. 211726, these twelve compounds also showed remarkable broad-spectrum antimicrobial activity. Moreover, they had moderate cytotoxicity, and the acute toxicity (LD~50~) of a mixture of twelve azalomycin F analogs produced by this strain was 97.9 mg/kg in mice by intraperitoneal injection.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotations were measured in methanol using an Autopol Ш digital polarimeter. UV spectra were determined by DU-800 UV/Visible spectrophotometer. IR spectra were obtained with Thermo Nicolet 380 FTIR spectrometer. All NMR experiments were recorded on a Bruker AV-400 NMR spectrometer equipped with a 5 mm PABBO BB-probe head (400 MHz for ^1^H shifts relative to MeOH-*d*~4~ at 3.31 ppm and 100 MHz for ^13^C shifts relative to MeOH-*d*~4~ at 49.05 ppm) at 30 °C. HR-ESI-MS spectra were carried on the API QSTAR Pulsar I MS System. Silica gel (Qingdao Haiyang Chemical Co. Ltd., Qingdao, China, 10--40 μm), octadecylsilyl silica gel (Silicycle, Quebec, Canada; 40--63 μm) and Sephadex LH-20 (Amersham Pharmacia Biotech AB, Uppsala, Sweden) were used for column chromatography. Precoated silica gel GF~254~ plates (Qingdao Haiyang Chemical Co., Ltd.) were used for thin layer chromatography. All compounds was prepared by Dionex Summit HPLC system (Dionex, Sunnyvale, CA, USA) consisting of Dionex P680 HPLC pumps (P680A HPG-4) with a UV detector (170 U), and a Shimadzu Shim-pack VP-ODS reversed-phase column (250 mm × 4.6 mm i.d., 5-μm particle size) was used.

3.2. Actinomycetes Material and Fermentation
--------------------------------------------

The strain of *Streptomyces* sp. 211726 was isolated from mangrove rhizosphere soil of *Heritiera globosa* collected in Wenchang, China. Voucher specimens are stored in Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan, China. The fermentation of strain*Streptomyces* sp. 211726 was reported in our previous paper \[[@B11-marinedrugs-11-00817]\]. In short, the strain of *Streptomyces* sp. 211726 was cultured with liquid medium containing glucose 1.0%, soluble starch 3.5%, yeast 0.2%, casein 0.4% and NaCl 1.8% (pH 7.2 before autoclaving), and incubated at 30 °C for 10 days on a rotary shaker at 190 rpm until 100 L of broth was obtained.

3.3. Extract and Isolation
--------------------------

After the 100 L broth of *Streptomyces* sp. 211726 was centrifuged, the mycelia was extracted with methanol, concentrated under vacuum and freeze-dried to obtain lyophilized powder. The powder was dissolve in CHCl~3~:MeOH (80:20), and separated into eight fractions (1--8) on a silica gel column using gradient elution of CHCl~3~:MeOH (3:1, 2:1 and 1:1). Fraction 2 was purified by reversed-phase C~18~ column eluted with MeOH:H~2~O (60:40), semi-preparative reversed-phase C~18~ high performance liquid chromatography eluted with MeOH:H~2~O (58:42) to give three pure fraction, and which were respectively concentrated under vacuum to obtain three extracts. These extracts were respectively dissolved in MeOH, purified by sephadex LH-20 column eluted with MeOH, concentrated under vacuum at 35 °C, and dried to give **1** (41 mg), **2** (22 mg) and **3** (31 mg). Similarly, fraction 3 was purified by reversed-phase C~18~ column eluted with MeOH:H~2~O (65:35), semi-preparative reversed-phase C~18~ high performance liquid chromatography eluted with MeOH:H~2~O (63:37) and sephadex LH-20 column eluted with MeOH to give **4** (15 mg) and **6** (27 mg); Fraction 4 was purified by reversed-phase C~18~ column eluted with MeOH:H~2~O (70:30), semi-preparative reversed-phase C~18~ high performance liquid chromatography eluted with MeOH:H~2~O (68:32) and sephadex LH-20 column eluted with MeOH to give **5** (10 mg) and **7** (24 mg).

25-Malonyl demalonylazalomycin F~5a~ monoester (**1**): White amorphous powder; \[α\]~D~^29^ +6.7° (*c* 0.1, MeOH); UV λ^MeOH^~max~ nm (log ε): 241(4.6), 269(4.3); IR υ^KBr^~max~ (cm^−1^): 3385, 2964, 2936, 1701, 1636, 1597, 1459, 1243, 1089, 1066, 969; ^13^C NMR (MeOH-*d*~4~, 100 MHz) and ^1^H NMR (MeOH-*d*~4~, 400 MHz) data were showed in [Table 1](#marinedrugs-11-00817-t001){ref-type="table"}; HRESIMS *m*/*z* 1096.6914 \[M + H\]^+^ (calcd. for C~57~H~98~N~3~O~17~, 1096.6896).

23-Valine demalonylazalomycin F~5a~ ester (**2**): White amorphous powder; \[α\]~D~^29^ +4.4° (*c* 0.1, MeOH); UV λ^MeOH^~max~ nm (log ε): 241(4.6), 268(4.4); IR υ^KBr^~max~ (cm^−1^): 3414, 3137, 2965, 2928, 1726, 1635, 1597, 1507, 1261, 1092, 968; ^13^C NMR (MeOH-*d*~4~, 100 MHz) and ^1^H NMR (MeOH-*d*~4~, 400 MHz) data were showed in [Table 1](#marinedrugs-11-00817-t001){ref-type="table"}; HRESIMS *m*/*z* 1109.7580 \[M + H\]^+^ (calcd. for C~59~H~105~N~4~O~15~, 1109.7576).

23-(6-Methyl)heptanoic acid demalonylazalomycin F~3a~ ester (**3**): White amorphous powder; \[α\]~D~^20^ +6.8° (*c* 0.1, MeOH); UV λ^MeOH^~max~ nm (log ε): 238(4.6), 269(4.3); IR υ^KBr^~max~ (cm^−1^): 3423, 2962, 2935, 1736, 1707, 1637, 1184, 1045, 970, 721; ^13^C NMR (MeOH-*d*~4~, 100 MHz) and ^1^H NMR (MeOH-*d*~4~, 400 MHz) data were showed in [Table 1](#marinedrugs-11-00817-t001){ref-type="table"}; HRESIMS *m*/*z* 1108.7638 \[M + H\]^+^ (calcd. for C~60~H~106~N~3~O~15~, 1108.7624).

23-(6-Methyl)heptanoic acid demalonylazalomycin F~4a~ ester (**4**): White amorphous powder; \[α\]~D~^20^ +6.4° (*c* 0.1, MeOH); UV λ^MeOH^~max~ nm (log ε): 238(4.5), 269(4.4); IR υ^KBr^~max~ (cm^−1^): 3423, 2965, 2936, 1734, 1708, 1635, 1181, 1049, 972, 722; ^1^H NMR (MeOH-*d*~4~, 400 MHz) and ^13^C NMR (MeOH-*d*~4~, 100 MHz) data were showed in [supplementary file](#marinedrugs-11-00817-s001){ref-type="supplementary-material"}; HRESIMS *m*/*z* 1122.7788 \[M + H\]^+^ (calcd. for C~61~H~108~N~3~O~15~, 1122.7780).

23-(6-Methyl)heptanoic acid demalonylazalomycin F~5a~ ester (**5)**: White amorphous powder; \[α\]~D~^20^ +6.1° (*c* 0.1, MeOH); UV λ^MeOH^~max~ nm (log ε): 238(4.5), 269(4.4); IR υ^KBr^~max~ (cm^−1^): 3425, 2963, 2935, 1734, 1708, 1636, 1185, 1047, 972, 721; ^1^H NMR (MeOH-*d*~4~, 400 MHz) and ^13^C NMR (MeOH-*d*~4~, 100 MHz) data were showed in [supplementary file](#marinedrugs-11-00817-s001){ref-type="supplementary-material"}; HRESIMS *m*/*z* 1136.7956 \[M + H\]^+^ (calcd. for C~62~H~110~N~3~O~15~, 1136.7937).

23-(9-Methyl)decanoic acid demalonylazalomycin F~4a~ ester (**6**): White amorphous powder; \[α\]~D~^20^ +6.0° (*c* 0.1, MeOH); UV λ^MeOH^~max~ nm (log ε): 238(4.5), 269(4.4); IR υ^KBr^~max~ (cm^−1^): 3425, 2968, 2935, 1734, 1708, 1636, 1185, 1047, 972, 721; ^1^H NMR (MeOH-*d*~4~, 400 MHz) and ^13^C NMR (MeOH-*d*~4~, 100 MHz) data were showed in [Table 1](#marinedrugs-11-00817-t001){ref-type="table"}; HRESIMS *m*/*z* 1164.8269 \[M + H\]^+^ (calcd. for C~64~H~114~N~3~O~15~, 1164.8250).

23-(10-Methyl)undecanoic acid demalonylazalomycin F~4a~ ester (**7**): White amorphous powder; \[α\]~D~^20^ +6.0° (*c* 0.1, MeOH); UV λ^MeOH^~max~ nm (log ε): 238(4.5), 269(4.4); IR υ (cm^−1^): 3425, 2968, 2936, 1736, 1707, 1636, 1185, 1047, 972, 721; ^13^C NMR (MeOH-*d*~4~, 100 MHz) and ^1^H NMR (MeOH-*d*~4~, 400 MHz) data were showed in [supplementary file](#marinedrugs-11-00817-s001){ref-type="supplementary-material"}; HRESIMS *m*/*z* 1178.8426 \[M + H\]^+^ (calcd. for C~65~H~116~N~3~O~15~, 1178.8406).

3.4. Biological Assays
----------------------

The MICs of all compounds against *C*. *albicans* ATCC 10231, *S*. *aureus* S014, *B*. *subtilis* S028 and *E*. *coli* S002 were determined by agar dilution method. Amphotericin B for *C*. *albicans*, oxacillin sodiumfor *S*. *aureus* and *B*. *subtilis* and kalamycin for *E*. *coli* were respectively used as positive controls. Yeast extract-peptone-dextrose (YPD) medium was used for *C. albicans*, beef extract-peptone medium was used for *S. aureus* and *B. subtilis*, and Luria-Bertani (LB) medium was used for *E*. *coli*. Their cytotoxicities were evaluated by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) method using human colon tumor cell HCT-116, and doxorubicin was used as a positive control.

4. Conclusions
==============

Proceed with research on minor azalomycin F analogs produced by *Streptomyces* sp. 211726, seven new compounds were isolated and identified. Biological assays of **1**--**7** showed remarkable antifungal and antibacterial activity and moderate cytotoxicity against human colon tumor cell HCT-116 *in vitro*.
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